Health
Study finds short window for donating convalescent plasma to COVID-19 patients – Medical Xpress
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration…
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study. The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is older than 30 and whose illness had been severe.
“Millions of individuals worldwide have recovered from COVID-19 and may be…
-
Noosa News17 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General15 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Business18 hours agoSolid superannuation gains continue to roll in
-
General9 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate